No image

TruSight™ Oncology RNA Control

20065042 · Illumina, Inc.

The TruSight Oncology DNA Control and TruSight Oncology RNA Control are control materials sold separately for use as a quality control to monitor analytical performance of the library preparation, sequencing, and analysis steps of Next Generation Sequencing based molecular diagnostic assays used for the detection of select DNA and RNA variants.

Details

Device typeCancer-related multiple gene mutation profile IVD, control: A material which is used to verify the performance of an assay intended to be used for genomic profiling/screening of multiple genes associated with cancer to detect specific types of mutations [e.g., single nucleotide variants (SNVs), insertions, deletions, fusions, translocations and/or copy number variations (CNVs)] in a clinical specimen.

FDA categoryDna And Rna Oncology Controls

Device ID00816270020644

AvailabilityPrescription

MRI safetyLabeling does not contain MRI Safety Information

Contact

Phone800-809-4566

Emailtechsupport@illumina.com

Related products

Product	Model	Company	Device type
TruSight™ Oncology DNA Control v2Illumina, Inc.Cancer-related multiple gene mutation profile IVD, control	20090155	Illumina, Inc.	Cancer-related multiple gene mutation profile IVD, control
Oncomine™ Dx Target TestLife Technologies CorporationMultiple tissue-associated protein/tumour marker IVD, reagent	A32441	Life Technologies Corporation	Multiple tissue-associated protein/tumour marker IVD, reagent
oncoReveal CDx Box 3Pillar Biosciences, Inc.Colorectal cancer genotyping IVD, kit, nucleic acid technique (NAT)	HDA-LC-2001-48-3	Pillar Biosciences, Inc.	Colorectal cancer genotyping IVD, kit, nucleic acid technique (NAT)
Idylla™ MSI FFPE Reference SetSensID GmbHExogenous DNA/RNA internal control IVD, kit	2x5	SensID GmbH	Exogenous DNA/RNA internal control IVD, kit